PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
05-Feb-2024 OptiBrand Rx Announces Partnership With Miami Dolphins Newswire
05-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
05-Feb-2024 Breaking Boundaries in Medical Device Sterilization: 5th Edition Excellence Conference marcus evans
03-Feb-2024 Napoli Shkolnik Files Amended Complaint in Class Action Lawsuit: Adds Medical Monitoring Sub-Class for Children & Families Businesswire
02-Feb-2024 Orano Med Lays Foundations for New Manufacturing Site for the Production of Lead-212 Radioligand Therapies Businesswire
02-Feb-2024 Implanet Announces the Success of Its Capital Increase Businesswire
02-Feb-2024 DoseMe Expands Its Reseller Agreement with Primum Pharma into the MEA Market Businesswire
02-Feb-2024 Delta-Fly Pharma Inc.: Bekanntmachung des Beginns einer klinischen Phase-III-Vergleichsstudie mit DFP-14323 Businesswire
02-Feb-2024 Alberto Bona and the Class40 IBSA Go to USA and Canada Businesswire
02-Feb-2024 Global Medical Aesthetics Market to Surge with Technological Advancements and Male Participation - ResearchAndMarkets.com Businesswire
02-Feb-2024 Revance Receives Permanent J-Code for DAXXIFY® and Announces Publication of DAXXIFY Pivotal Study (ASPEN-1) Results in Neurology® Businesswire
02-Feb-2024 Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024 Businesswire
02-Feb-2024 Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer Businesswire
02-Feb-2024 Asia-Pacific Functional Genomics Market: Analysis and Forecasts 2023-2033: Collaborations Foster Innovations, Efficient Instruments Shape the Future of the Landscape - ResearchAndMarkets.com Businesswire
02-Feb-2024 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Feb-2024 Zura Bio Announces Participation at February Investor Conferences Businesswire
02-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Feb-2024 Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults Napp Pharmaceuticals Limited
02-Feb-2024 Riassunto: Delta-Fly Pharma Inc.: avviso di avvio dello studio clinico comparativo pivotale di fase III di DFP-14323 Businesswire
02-Feb-2024 Samenvatting: Delta-Fly Pharma Inc.: kennisgeving van initiatie van cruciale vergelijkende klinische studie Fase III van DFP-14323 Businesswire